Michael Harrison
@MRHarrisonMD
Followers
721
Following
1K
Media
25
Statuses
482
GU medical oncologist, Associate Professor of Medicine, and clinical researcher at Duke Cancer Institute. All tweets and views my own.
Durham, NC
Joined May 2015
@hannahdzmd highlighting combos w #PSMAlutetium — We are doing combo w ONC-392 @utswcancer! New IIT @DukeGUCancer w/ cabozantinib & lutetium in metastatic #prostatecancer. IITs are hard to open — kudos to the team @MRHarrisonMD @Daniel_J_George @AarmstrongDuke! @DAVAOnc #DAVAGU
0
3
17
I would happily wear this t-shirt! @fitaftercancer
Need impactful message for exercise oncology awareness and to spark action. Exercise reduces cancer specific mortality by >30% for breast, colon, prostate, yet most patients never get this information. Thoughts on this message? Will it spark debate? Would you wear this T?
0
0
8
I appreciate @Uromigos getting down to brass tacks as to how trial data affects day to day clinical GU practice! Great insights from community oncology colleagues. @GUconference #WorldGU24
#WorldGU24 An amazing session with The @Uromigos @tompowles1 @brian_rini with community oncologists to discuss the real world practice patterns in GU cancers.
2
5
25
Despite being negative, CONTACT-03 is one of the most important studies in mRCC. With negative TiNivo-2, while disappointing, both give us confidence to DC PD-1 after progression & avoid tox. @brian_rini @tompowles1 @Uromigos @GUconference #WorldGU24
1
0
10
Despite being negative, CONTACT-03 is one of the most important studies in mRCC. With negative TiNivo-2, while disappointing, both give us confidence to DC PD-1 after progression & avoid tox. @brian_rini @tompowles1 @Uromigos @GUconference #WorldGU24
1
2
25
Singing and dancing by the Rat Pack & Rockettes to open the day (New York, New York!) and introduce “the real chairman of the board” @Daniel_J_George!
0
2
11
Ready for day 2 (bladder cancer) of #WorldGU24! @GUconference What will the opening ceremony be?
0
0
5
Important data by @Daniel_J_George, @hannahdzmd & colleagues from @IRONMANregistry showing how generalizable mHSPS combo therapy data is to real world practice! Kudos to @GUconference for elevating the voices of emerging stars in the field.
Great start to @GUconference with an interactive poster session. @hannahdzmd discussing high uptake of combined therapy for mHSPC in @IRONMANregistry @loreleimucci
0
0
2
No dry eyes w @GUconference #WorldGU24 keynote @JOLearyInspires last night. The “On Fire” author modeled vulnerable authentic leadership, discussing his burns at age 9 & recovery path, aided by amazing people. Still plays piano despite injuries. Awaiting the movie in 2025!
0
2
10
A view from the stage during the hilarious & enlightening IO-IO vs IO-TKI debate between @DrRanaMcKay & #DavidMcDermott.
Come for the #kidneycancer updates, stay for the breakdancing. 🥰 Kudos @DrRanaMcKay winning this IO/TKI vs IO/IO round w #DavidMcdermott @Uromigos #WorldGU24
0
0
5
Awesome to present on favorable risk mRCC at #worldgu24 with such luminaries as @TiansterZhang @EJonasch @DrRanaMcKay & @Daniel_J_George! Goals of care (GOC) discussions are particularly important in this group of pts who have multiple options (including no treatment at all).
1
1
10
Very excited to share with you incredibly promising data for #zanzalintinib (#XL092) in patients with #kidneycancer. A million thanks to @kidneycancer for allowing us to present this data in a highlighted oral session at #IKCSNA23! See my slides/thoughts here: (1/9)
4
47
171
This #OpenAccess review summarizes key topics discussed to advance research on the role of energy balance, including physical activity, body composition, and dietary intake, on cancer development, cancer outcomes, and healthy survivorship. 🔗 https://t.co/P2xBWq9EEH
0
40
67
A #pulmonaryfibrosis patient rode his bicycle on a 2-day trip from Virginia to demonstrate his recovery from a #lungtransplant on his one-year check-up. @DukeCTSurgery | @DukeSurgery | @DukeHeartCenter | #LungTransplant | #PulmonaryFibrosis
1
6
36
New table of IO doublets in sarcomatoid RCC: 1. Central path review done for ipi/nivo while other datasets relied on local path report 2. IO/VEGF with very short f/u and thus wide CIs 3. Ipi/nivo notable for high CR rate and high landmarks with long f/u 4. No detailed CLEAR data
1
95
212
A new era begins @DukeHealth @DukeMedSchool @DukeUrology First surgery as the Department of Urology. @DukeUroRes @DukePedsUro
5
5
94
Congrats @tomleblancMD!
Chief Patient Experience and Safety Officer @DukeCancer @TomLeblancMD was named chair of the #ASCO24 Annual Meeting Education Program Committee. He is @DukeMedicine faculty, a #PalliativeCare and @DukeHMCT doc, and an @ASCO Fellow and Advocacy Champion.
0
0
2
Going away party for our great friend and colleague Dr Brant Inman who is departing @DukeUrology @DukeCancer @DukeGUCancer and returning to Canada. We wish him well but he will be so hard to replace - amazing surgeon and brilliant researcher @Daniel_J_George @AarmstrongDuke
3
6
51
Microbiome metabolites associated with worse outcomes on immunotherapy in RCC pts. Thrilled to welcome @BariShahlaMD to @DukeGUCancer. Thanks @PCFnews for her #YoungInvestigatorAward
0
11
28
